beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.
about
Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and diseaseAdaptation of myocardial substrate metabolism to a ketogenic nutrient environment.Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticityCompetition between acetate and oleate for the formation of malonyl-CoA and mitochondrial acetyl-CoA in the perfused rat heart.Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidationThe Failing Heart Relies on Ketone Bodies as a Fuel.Ketone body metabolism and cardiovascular diseaseCompound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia.Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.Probing early heart development to instruct stem cell differentiation strategies.Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.Oxidation of Intracellular and Extracellular Fatty Acids in Skeletal Muscle: Application of kinetic modeling, stable isotopes and liquid chromatography/electrospray ionization ion-trap tandem mass spectrometry technology.Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Regulation of myocardial substrate metabolism during increased energy expenditure: insights from computational studies.Loss of Metabolic Flexibility in the Failing Heart.
P2860
Q26828498-97D06946-74E6-4A5D-92FE-2464489BFE26Q34042546-6BBFF68C-92FA-4DE9-A82B-521BFA8C0021Q34213572-C7DF56AE-13CD-4B23-8072-95C59FDC2C72Q35928419-74F9D249-7CD0-4B1A-AEBF-DC76F078E9AFQ36593104-AC4E3EF6-6EA6-47F5-A012-789135DE0B08Q36614537-29F62F87-DFA3-414B-A74A-AFAEBD717B50Q36764435-F29C2A82-6025-4247-98DC-8B6CAD06A0DFQ37460223-ADDF3CA3-87FB-42CB-89B8-25DCD54AF6C4Q38129182-7BA5AA1D-F752-46AB-9A0C-29AD3B52B75CQ38825941-9A9C487B-7443-4DEE-B3C3-B723F886DD49Q39126658-13569D4E-3B38-48A1-81D4-79EFB8D6F120Q39991764-DC25440A-3328-47C6-BFF8-91C1523ED7AAQ41104002-B4B96B5C-B27B-4345-B73E-9FCADC39D086Q42487926-CDF508A3-B772-4E26-8487-9B473DE8BABAQ46430416-B963025F-4A39-49D3-8EBA-18C73AA8C2FAQ46697072-CD28D65B-98B0-4D51-ADBA-918D6C3C07D0Q47739163-7883D85C-221B-4595-92B2-243435CA9363Q51230126-0636E9C0-952A-495E-B1FF-663C2F447400Q55341036-65D888CC-6AAF-4071-9C3B-3FEFD3087063
P2860
beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@en
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@nl
type
label
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@en
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@nl
prefLabel
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@en
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@nl
P2093
P2860
P1476
beta-Hydroxybutyrate inhibits ...... hanges in malonyl-CoA content.
@en
P2093
Bridgette A Roth
Gary D Lopaschuk
Krista M Kivilo
Steven R Meadows
William C Stanley
P2860
P304
P356
10.1152/AJPHEART.00332.2003
P577
2003-10-01T00:00:00Z